Product Information |
|
Registration Number |
BR-1307
|
Generic Name |
Varicella Vaccine (Live, Attenuated)
|
Brand Name |
Varilrix
|
Dosage Strength |
Formulation:
After reconstitution, one dose (0.5 mL) contains not less than 103.3 plaque-forming units (PFU) live attenuated varicella-zoster virus (Oka Strain).
|
Dosage Form |
Lyophilized Powder For Injection (S.C.)
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
Vaccine
|
Packaging |
Type I colorless glass vial with bromobutyl rubber stopper and flip-off cap + 0.5 mL Type I pre-filled glass syringe (Water for Injection as diluent) with 2 separate needles (Box of 1's)
|
Manufacturer |
GlaxoSmithKline Biologicals SA
|
Country of Origin |
Belgium
|
Trader |
N/A
|
Importer |
GlaxoSmithKline Philippines, Inc.
|
Distributor |
GlaxoSmithKline Philippines, Inc.
|
Application Type |
Initial (Variation)
|
Issuance Date |
25 July 2023
|
Expiry Date |
25 July 2028
|